[Subtypes of muscarinic receptors--aspects of their physiologic significance for controlling heart rate in the human]
- PMID: 7846951
[Subtypes of muscarinic receptors--aspects of their physiologic significance for controlling heart rate in the human]
Abstract
The cDNAs for five different muscarinic cholinoceptors have been cloned. The biochemical and physiological relevance of the m1, m2 and m3 receptors is understood in many aspects. The pharmacological defined M1, M2 and M3 related to antagonists binding studies closely correspond with those cloned. We compared effects of atropine and of the subtype selective M-cholinoceptor antagonists pirenzepine and AF-DX 116 in humans. Dose- or time-response curves have been established for heart rate. Plasma samples were drawn in parallel with the effect measurements and analysed for drug concentrations. Subtype-selective radioceptor assays of the samples served to estimate the respective receptor occupancy in vivo. After low dosis of pirenzepine (M1-selective blockade) a negative chronotropic effect on heart rate could be observed. After high doses of pirenzepine or atropine (M-unselective blockade) the wellknown tachycardia appeared in parallel with occupancy of both the M2 and M3 subtypes. AF-DX 116 induced a tachycardia without a decrease of salivary flow in agreement with its selectivity profile (M2 > M1 > M3). Gastric emptying was only slightly inhibited by AF-DX 116 but nearly completely by a very high dose of pirenzepine blocking M1-, M2- and M3-cholinoceptors. The negative chronotropic effect on heart rate of a low dose of pirenzepine (M1 selective) was multi-folded by pretreatment with isoprenaline but disappeared during bicycle exercise. The implications of the functional M cholinoceptor heterogeneity in humans revealed by antagonists are discussed according to its possible importance for the control of autonomous nerve system.
Similar articles
-
Selective antagonists reveal different functions of M cholinoceptor subtypes in humans.Trends Pharmacol Sci. 1989 Dec;Suppl:92-6. Trends Pharmacol Sci. 1989. PMID: 2694532 Review.
-
Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancy.Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):207-10. doi: 10.1007/BF00174872. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3185747
-
AF-DX 116 discriminates heart from gland M2-cholinoceptors in man.Life Sci. 1989;45(6):493-8. doi: 10.1016/0024-3205(89)90099-4. Life Sci. 1989. PMID: 2770414
-
Cardiopulmonary actions of muscarinic receptor subtypes in the newborn dog.Can J Physiol Pharmacol. 1996 May;74(5):603-13. Can J Physiol Pharmacol. 1996. PMID: 8884027
-
Muscarinic receptors and drugs in cardiovascular medicine.Cardiovasc Drugs Ther. 1995 Feb;9(1):159-67. doi: 10.1007/BF00877757. Cardiovasc Drugs Ther. 1995. PMID: 7786837 Review.
Cited by
-
Opinion on the impact of non-monotonic dose responses on EFSA's human health risk assessments.EFSA J. 2021 Oct 20;19(10):e06877. doi: 10.2903/j.efsa.2021.6877. eCollection 2021 Oct. EFSA J. 2021. PMID: 34712366 Free PMC article.